Literature DB >> 34663503

Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis.

Antonio Terracciano1, Murat Bilgel2, Damaris Aschwanden3, Martina Luchetti4, Yannick Stephan5, Abhay R Moghekar6, Dean F Wong7, Luigi Ferrucci2, Angelina R Sutin4, Susan M Resnick2.   

Abstract

BACKGROUND: Higher neuroticism and lower conscientiousness are risk factors for Alzheimer's disease and related dementias, but the underlying neuropathological correlates remain unclear. Our aim was to examine whether personality traits are associated with amyloid and tau neuropathology in a new sample and meta-analyses.
METHODS: Participants from the BLSA (Baltimore Longitudinal Study of Aging) completed the Revised NEO Personality Inventory and underwent amyloid (11C-labeled Pittsburgh compound B) and tau (18F-flortaucipir) positron emission tomography.
RESULTS: Among cognitively normal BLSA participants, neuroticism was associated with higher cortical amyloid burden (odds ratio 1.68, 95% CI 1.20-2.34), and conscientiousness was associated with lower cortical amyloid burden (odds ratio 0.61, 95% CI 0.44-0.86). These associations remained significant after accounting for age, sex, education, depressive symptoms, hippocampal volume, and APOE ε4. Similar associations were found with tau in the entorhinal cortex. Random-effects meta-analyses of 12 studies found that higher neuroticism (N = 3015, r = 0.07, p = .008) and lower conscientiousness (N = 2990, r = -0.11, p < .001) were associated with more amyloid deposition. Meta-analyses of 8 studies found that higher neuroticism (N = 2231, r = 0.15, p < .001) and lower conscientiousness (N = 2206, r = -0.14, p < .001) were associated with more tau pathology. The associations were moderated by cognitive status, with stronger effects in cognitively normal compared with heterogeneous samples, suggesting that the associations between personality and proteopathies are not phenomena that emerge with neuropsychiatric clinical symptoms.
CONCLUSIONS: By aggregating results across samples, this study advances knowledge on the association between personality and neuropathology. Neuroticism and conscientiousness may contribute to resistance against amyloid and tau neuropathology.
Copyright © 2021 Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Amyloid; Meta-analysis; Neuropsychiatric disorders; Personality; Tau

Mesh:

Substances:

Year:  2021        PMID: 34663503      PMCID: PMC8792161          DOI: 10.1016/j.biopsych.2021.08.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  81 in total

1.  Good News for Dementia Prevention: Multiple Behavioral Features Are Associated With Markers of Brain Pathology in the Preclinical Phase of Sporadic and Autosomal Dominant Alzheimer's Disease.

Authors:  Sharon Sanz Simon
Journal:  Biol Psychiatry       Date:  2021-04-15       Impact factor: 13.382

2.  Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.

Authors:  Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk
Journal:  Am J Geriatr Psychiatry       Date:  2015-02-11       Impact factor: 4.105

3.  Personality factors and cerebral glucose metabolism in community-dwelling older adults.

Authors:  Hamid R Sohrabi; Kathryn Goozee; Michael Weinborn; Kaikai Shen; Belinda M Brown; Stephanie R Rainey-Smith; Olivier Salvado; Kevin Taddei; Romola S Bucks; Paul Maruff; Simon M Laws; Nat Lenzo; Manja Laws; Colin DeYoung; Craig Speelman; Christoph Laske; David Ames; Greg Savage; Ralph N Martins
Journal:  Brain Struct Funct       Date:  2020-04-27       Impact factor: 3.270

4.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

5.  Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies.

Authors:  Kristian Steen Frederiksen; Le Gjerum; Gunhild Waldemar; Steen Gregers Hasselbalch
Journal:  Curr Alzheimer Res       Date:  2019       Impact factor: 3.498

6.  Depression, dementia and immune dysregulation.

Authors:  Shawn Hayley; Antoine M Hakim; Paul R Albert
Journal:  Brain       Date:  2021-04-12       Impact factor: 13.501

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment.

Authors:  Robert S Wilson; Julie A Schneider; Steven E Arnold; Julia L Bienias; David A Bennett
Journal:  Arch Gen Psychiatry       Date:  2007-10

9.  Polygenic Score for Alzheimer Disease and cognition: The mediating role of personality.

Authors:  Yannick Stephan; Angelina R Sutin; Martina Luchetti; Pauline Caille; Antonio Terracciano
Journal:  J Psychiatr Res       Date:  2018-10-23       Impact factor: 4.791

10.  Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.

Authors:  Christopher A Lane; Josephine Barnes; Jennifer M Nicholas; Carole H Sudre; David M Cash; Ian B Malone; Thomas D Parker; Ashvini Keshavan; Sarah M Buchanan; Sarah E Keuss; Sarah-Naomi James; Kirsty Lu; Heidi Murray-Smith; Andrew Wong; Elizabeth Gordon; William Coath; Marc Modat; David Thomas; Marcus Richards; Nick C Fox; Jonathan M Schott
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

View more
  1 in total

1.  Facets of Personality and Risk of Cognitive Impairment: Longitudinal Findings in a Rural Community from Sardinia.

Authors:  Antonio Terracciano; Maria Rita Piras; Angelina R Sutin; Alessandro Delitala; Nicolò Camillo Curreli; Lenuta Balaci; Michele Marongiu; Xianghe Zhu; Damaris Aschwanden; Martina Luchetti; Richard Oppong; David Schlessinger; Francesco Cucca; Lenore J Launer; Edoardo Fiorillo
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.